The Efficacy of Pantoprazole Treatment in Patients With Functional Dyspepsia

Phase 4

• Conditions: Nonulcer Dyspepsia
• Interventions: Drug: Folic Acid; Drug: Pantoprazol

• Registration Number: NCT01608750
• Lead Sponsor: Bezmialem Vakif University

Brief Summary

The aim of our study is to evaluate the effectiveness of proton pump inhibitor (PPI) treatment in patients with functional dyspepsia.

Detailed Description

Not available

Study Timeline

• Status Verified: 2012-05
• Study First Submitted: 2012-05-28
• Study First Submitted QC: 2012-05-30
• Last Update Submitted: 2012-05-30
• Study First Posted: 2012-05-31
• Last Update Posted: 2012-05-31
• Study Start: 2012-06
• Primary Completion: 2012-12
• Study Completion: 2013-06

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• aged 18-45 years with symptoms of dyspepsia,
• no evidence of organic disease.

Exclusion Criteria

• Patients with alarm symptoms,
• Severe concomitant illness,
• Pregnancy or lactation,
• Alcohol or drug abuse,
• Use of aspirin or other non-steroidal anti-inflammatory drugs antibiotics, H2 receptor blockers, bismuth, or proton pump inhibitors in the preceding two weeks

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
folic acid	Folic Acid	-
pantoprazole	Pantoprazol	-

Primary Outcome Measures

Name	Time	Method
Effectiveness of pantoprazole treatment in patients with functional dyspepsia measured by symptoms scale.	one year

Trial Locations

Locations (1)

Bezmialem medical faculty; 🇹🇷 Istanbul, Turkey